Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan in reward reinforcement learning
NCT04604938Unknown
- Sponsor
- University of Electronic Science and Technology of China
- Start
- Oct 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in substance-related disorders comparing Losartan group with Placebo group (2 arms). Primary endpoints: BOLD-level activity during the learning phase and BOLD-level activity during the learning transfer phase. Status: unknown.
02
Drugs
losartan
03
Conditions
substance-related disorders
Beyond the preview
Go deeper on NCT04604938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04604938.